Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:administered_by |
oral tablet
|
| gptkbp:casnumber |
123456-78-9
|
| gptkbp:chemical_formula |
C23 H30 N2 O3
|
| gptkbp:developed_by |
gptkb:Sorrento_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
SR 906
|
| gptkbp:mechanism_of_action |
CB1 receptor agonist
|
| gptkbp:status |
gptkb:Clinical_Trials
|
| gptkbp:targets |
cannabinoid receptors
|
| gptkbp:type |
synthetic cannabinoid
|
| gptkbp:used_for |
pain management
|
| gptkbp:bfsParent |
gptkb:I-90_Snoqualmie_Pass
|
| gptkbp:bfsLayer |
7
|